Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4076
Strata Critical Medical Inc
SRTA
$534M
| $150K | ﹤0.01% |
29,269
-31,600
| -52% | -$172K |
2022 Q1
18 quarters
|
|
4077
Nautilus Biotechnolgy
NAUT
$311M
| $149K | ﹤0.01% |
105,225
-620,096
| -85% | -$736K |
2022 Q1
18 quarters
|
|
4078
Universal Electronics
UEIC
$75.5M
| $149K | ﹤0.01% |
28,608
-122
| -0.4% | -$589 |
2016 Q1
42 quarters
|
|
4079
Atlanta Braves Holdings Series A
BATRA
$3.69B
| $149K | ﹤0.01% |
2,573
+1,585
| +160% | +$89K |
2023 Q4
11 quarters
|
|
4080
CuriosityStream
CURI
$140M
| $149K | ﹤0.01% |
51,286
+9,343
| +22% | +$25.7K |
2024 Q4
7 quarters
|
|
4081
Yatsen Holding
YSG
$184M
| $149K | ﹤0.01% |
53,681
| – | – |
2022 Q1
18 quarters
|
|
4082
BNB Standard Corporation Common Stock
BNC
$229M
| $149K | ﹤0.01% |
+25,318
| New | +$89.1K |
2026 Q3
0 quarters
|
|
4083
FT Vest U.S. Equity Max Buffer ETF - October
OCTM
$36.1M
| $149K | ﹤0.01% |
4,341
| – | – |
2024 Q4
7 quarters
|
|
4084
Parke Bancorp
PKBK
$386M
| $148K | ﹤0.01% |
4,531
+2,954
| +187% | +$100K |
2022 Q2
17 quarters
|
|
4085
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$138M
| $148K | ﹤0.01% |
3,268
| – | – |
2024 Q3
8 quarters
|
|
4086
OP Bancorp
OPBK
$224M
| $148K | ﹤0.01% |
9,870
+2,213
| +29% | +$33.8K |
2024 Q3
8 quarters
|
|
4087
Design Therapeutics
DSGN
$686M
| $148K | ﹤0.01% |
11,771
+64
| +0.5% | +$884 |
2022 Q1
18 quarters
|
|
4088
Innovator Equity Managed 10 Buffer ETF
XBFR
$45.7M
| $148K | ﹤0.01% |
+5,503
| New | +$147K |
2026 Q3
0 quarters
|
|
4089
Icahn Enterprises
IEP
$3.8B
| $148K | ﹤0.01% |
21,900
| – | – |
2020 Q4
23 quarters
|
|
4090
Fossil Group
FOSL
$575M
| $148K | ﹤0.01% |
22,470
-66,364
| -75% | -$336K |
2013 Q2
53 quarters
|
|
4091
Agenus
AGEN
$324M
| $147K | ﹤0.01% |
14,832
+5,635
| +61% | +$38.8K |
2014 Q2
49 quarters
|
|
4092
Nexa Resources
NEXA
$1.59B
| $147K | ﹤0.01% |
12,035
+11,307
| +1,553% | +$152K |
2023 Q3
12 quarters
|
|
4093
Bright Minds Biosciences
DRUG
$233M
| $146K | ﹤0.01% |
2,940
-316
| -10% | -$22.3K |
2025 Q2
5 quarters
|
|
4094
Inter&Co
INTR
$1.76B
| $146K | ﹤0.01% |
27,327
-10,184
| -27% | -$55.8K |
2025 Q4
3 quarters
|
|
4095
eGain
EGAN
$160M
| $146K | ﹤0.01% |
25,080
+2,995
| +14% | +$19.6K |
2018 Q1
34 quarters
|
|
4096
VSE Corp Tangible Equity Units
VSECU
$1.37B
| $145K | ﹤0.01% |
3,290
+3,000
| +1,034% | +$159K |
2026 Q2
1 quarter
|
|
4097
Latham Group
SWIM
$987M
| $145K | ﹤0.01% |
23,280
+14,871
| +177% | +$96.1K |
2022 Q1
18 quarters
|
|
4098
Odyssey Therapeutics
ODTX
$986M
| $145K | ﹤0.01% |
6,523
+5,064
| +347% | +$108K |
2026 Q2
1 quarter
|
|
4099
Tejon Ranch
TRC
$474M
| $145K | ﹤0.01% |
8,918
+5,549
| +165% | +$93.8K |
2016 Q3
40 quarters
|
|
4100
Rocky Brands
RCKY
$398M
| $144K | ﹤0.01% |
3,220
+2,079
| +182% | +$92.2K |
2018 Q2
33 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.